Search for a report

Reports

  • You are here:
  • Home
  • Downloads
  • ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET FORECAST 2022-2030

ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET FORECAST 2022-2030

The Asia-Pacific contrast enhanced ultrasound market is evaluated to progress with a CAGR of 5.54% during the forecasting period of 2022 to 2030, capturing a revenue share of $662.04 million by 2030.

ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET FORECAST 2022-2030

Asia-Pacific Contrast Enhanced Ultrasound Market by Product (Equipment, Contrast Agent) Market by Type (Non-targeted, Targeted) Market by End-user (Hospitals, Clinics, Ambulatory Diagnostic Centers) by Geography

Request free sample

The Asia-Pacific contrast enhanced ultrasound market is evaluated to progress with a CAGR of 5.54% during the forecasting period of 2022 to 2030, capturing a revenue share of $662.04 million by 2030.

The rapid improvement in healthcare expenditure, especially in emerging nations such as China and India, in addition to the lack of well-organized reimbursement policies that propel the demand for cost-effective procedures, are among the key factors influencing the growth of the region’s market. However, the Asia-Pacific contrast enhanced ultrasound market will likely be hindered by factors such as the challenging acquisition of skilled labor in remote regions.

Asia-Pacific Contrast Enhanced Ultrasound Market

To know more about this report, request a free sample copy

The Asia-Pacific contrast enhanced ultrasound market growth assessment covers the study of China, Japan, Singapore, Taiwan, Australia & New Zealand, India, South Korea, Indonesia, and Rest of Asia Pacific. The growth of the contrast enhanced ultrasound market in China is mainly attributable to shifting demographics and disease trends as well as the development of the private healthcare sector. Moreover, owing to the influx of foreign investments in the Chinese healthcare industry, numerous private hospitals are being established in the country every year. The COVID-19 pandemic has also emphasized the need for incorporating contrast enhanced ultrasound technology in point-of-care diagnostics. In addition, the rising geriatric population plays a pivotal role in fueling the demand for contrast enhanced ultrasound as the elderly are more susceptible to cardiovascular and digestive ailments.

Conversely, the majority of hospitals in Japan are equipped with modern and cutting-edge ultrasound devices. Aligning with this, the adoption of contrast enhanced ultrasonography is accelerating in the country due to supportive regulations for innovative technology as well as high healthcare costs. Since the use of contrast enhanced ultrasound technology has significantly increased in primary care facilities and clinics over recent years, this factor is expected to further fuel the market growth in the Asia-Pacific during the forecast period.

The Asia-Pacific contrast enhanced ultrasound market is segmented into product, type, and end-user. The end-user segment includes hospitals, clinics, and ambulatory diagnostic centers. The hospital segment has a greater share within the contrast enhanced ultrasound market on account of the presence of a large patient pool and an installed advanced ultrasound equipment base. Furthermore, the availability of technicians and doctors with advanced expertise in utilizing machinery and contrast agents is also predicted to support the segment’s expansion.

On the other hand, the adoption rate of ultrasound scanners in clinics and other community-level clinics has increased, owing to the rise in the knowledge of cost-saving measures for early disease identification. Moreover, ultrasounds are also effective diagnostic techniques for urology, cancer, and cardiac care. Hence, on account of the increasing use of ultrasound in these specialties, urology, cardiology, and oncology clinics are set to be prospective markets for contrast agents.

Major enterprises operating in the Asia-Pacific contrast enhanced ultrasound market include Trivitron Healthcare Pvt Ltd, Koninklijke Philips NV, etc.

Trivitron Healthcare Pvt Ltd, headquartered in India, is a medical technology company that offers solutions to healthcare providers. The company’s products include newborn screening, radiography and C-arm systems, mammography, contrast media, ultrasound, breast biopsy system, radiation protection, bone densitometer, renal care, ventilators, and others.

Iopamiro® is a US FDA-approved X-ray contrast agent for the diagnosis of radiological procedures in radiology, CT, HSG, urography, and others.

Report Synopsis

Report Scope Details
Market Forecast Years 2022-2030
Base Year 2021
Market Historical Years 2018-2021
Forecast Units Revenue ($ Million)
Segments Analyzed Product, Type, End-User
Countries Analyzed China, Japan, India, South Korea, Indonesia, Singapore, Taiwan, Australia & New Zealand, and Rest of Asia Pacific
Companies Analyzed

GE Healthcare, Bracco Diagnostic Inc, Trivitron Healthcare Pvt Ltd, Koninklijke Philips NV, Daiichi Sankyo Company, Limited, Siemens Healthineers AG, Lantheus Medical Imaging, Inc, Shenzhen Mindray Bio-Medical Electronics Co Ltd, NanoPET Pharma GmbH, Bayer AG, Taejoon Pharm Co Ltd, Sanochemia Pharmazeutika GmbH

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


    1. RESEARCH SCOPE & METHODOLOGY
      • STUDY OBJECTIVES
      • SCOPE OF STUDY
      • METHODOLOGY
      • ASSUMPTIONS & LIMITATIONS
    2. EXECUTIVE SUMMARY
      • MARKET SIZE & ESTIMATES
      • MARKET OVERVIEW
    3. MARKET DYNAMICS
      • KEY DRIVERS
        • SURGING PREVALENCE OF CHRONIC DISEASES
        • HEALTH PRACTITIONERS PREFER CONTRAST ENHANCED ULTRASOUND IMAGING
        • TECHNOLOGICAL ADVANCEMENTS IN DIAGNOSIS
      • KEY RESTRAINTS
        • NON-UNIFORMITY OF CONTRAST AGENTS
        • DIFFICULTY IN ADOPTION IN THE CURRENT HEALTHCARE SYSTEM
    1. KEY ANALYTICS
      • IMPACT OF COVID-19 ON CONTRAST ENHANCED ULTRASOUND MARKET
      • KEY MARKET TRENDS
      • PORTER’S FIVE FORCES ANALYSIS
        • BUYERS POWER
        • SUPPLIERS POWER
        • SUBSTITUTION
        • NEW ENTRANTS
        • INDUSTRY RIVALRY
      • OPPORTUNITY MATRIX
      • VENDOR LANDSCAPE
      • VALUE CHAIN ANALYSIS
      • KEY BUYING CRITERIA
        • COST EFFICIENCY
        • PRODUCT FEATURES
        • END-USE
      • REGULATORY FRAMEWORK
    2. MARKET BY PRODUCT
      • EQUIPMENT
      • CONTRAST AGENT
    3. MARKET BY TYPE
      • NON-TARGETED
      • TARGETED
    4. MARKET BY END-USER
      • HOSPITALS
      • CLINICS
      • AMBULATORY DIAGNOSTIC CENTERS
    5. GEOGRAPHICAL ANALYSIS
      • ASIA-PACIFIC
        • MARKET ESTIMATES & SIZES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • CHINA
          • JAPAN
          • INDIA
          • SOUTH KOREA
          • INDONESIA
          • SINGAPORE
          • TAIWAN
          • AUSTRALIA & NEW ZEALAND
          • REST OF ASIA-PACIFIC
    1. COMPETITIVE LANDSCAPE
      • KEY STRATEGIC DEVELOPMENTS
        • MERGERS & ACQUISITIONS
        • PRODUCT LAUNCHES & DEVELOPMENTS
        • PARTNERSHIPS & AGREEMENTS
        • BUSINESS EXPANSIONS & DIVESTITURES
      • COMPANY PROFILES
        • BAYER AG
        • BRACCO DIAGNOSTIC INC
        • DAIICHI SANKYO COMPANY LIMITED
        • GE HEALTHCARE
        • KONINKLIJKE PHILIPS NV
        • LANTHEUS MEDICAL IMAGING INC
        • NANOPET PHARMA GMBH
        • SANOCHEMIA PHARMAZEUTIKA GMBH
        • SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO LTD
        • SIEMENS HEALTHINEERS AG
        • TAEJOON PHARM
        • TRIVITRON HEALTHCARE

    LIST OF TABLES

    TABLE 1: ASIA-PACIFIC MARKET SNAPSHOT – CONTRAST ENHANCED ULTRASOUND

    TABLE 2: EXAMPLES OF CURRENT CLINICAL ULTRASOUND CONTRAST AGENTS

    TABLE 3: EXAMPLES OF EMERGING ULTRASOUND MICROBUBBLES-BASED TECHNIQUES

    TABLE 4: REGULATORY FRAMEWORK

    TABLE 5: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, BY PRODUCT, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 6: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, BY PRODUCT, FORECAST YEARS, 2022-2030 (IN $ MILLION)

    TABLE 7: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 8: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)

    TABLE 9: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, BY END-USER, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 10: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, BY END-USER, FORECAST YEARS, 2022-2030 (IN $ MILLION)

    TABLE 11: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 12: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

    TABLE 13: LEADING PLAYERS OPERATING IN ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET

    TABLE 14: LIST OF MERGERS & ACQUISITIONS

    TABLE 15: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

    TABLE 16: LIST OF PARTNERSHIPS & AGREEMENTS

    TABLE 17: LIST OF BUSINESS EXPANSIONS & DIVESTITURES   

    LIST OF FIGURES

    FIGURE 1: KEY MARKET TRENDS

    FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

    FIGURE 3: OPPORTUNITY MATRIX

    FIGURE 4: VENDOR LANDSCAPE

    FIGURE 5: VALUE CHAIN ANALYSIS

    FIGURE 6: KEY BUYING CRITERIA

    FIGURE 7: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2021

    FIGURE 8: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, BY EQUIPMENT, 2022-2030 (IN $ MILLION)

    FIGURE 9: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, BY CONTRAST AGENT, 2022-2030 (IN $ MILLION)

    FIGURE 10: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, GROWTH POTENTIAL, BY TYPE, IN 2021

    FIGURE 11: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, BY NON-TARGETED, 2022-2030 (IN $ MILLION)

    FIGURE 12: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, BY TARGETED, 2022-2030 (IN $ MILLION)

    FIGURE 13: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, GROWTH POTENTIAL, BY END-USER, IN 2021

    FIGURE 14: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, BY HOSPITALS, 2022-2030 (IN $ MILLION)

    FIGURE 15: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, BY CLINICS, 2022-2030 (IN $ MILLION)

    FIGURE 16: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, BY AMBULATORY DIAGNOSTIC CENTERS, 2022-2030 (IN $ MILLION)

    FIGURE 17: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN%)

    FIGURE 18: CHINA CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)

    FIGURE 19: JAPAN CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)

    FIGURE 20: INDIA CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)

    FIGURE 21: SOUTH KOREA CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)

    FIGURE 22: INDONESIA CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)

    FIGURE 23: SINGAPORE CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)

    FIGURE 24: TAIWAN CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)

    FIGURE 25: AUSTRALIA & NEW ZEALAND CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)

    FIGURE 26: REST OF ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)       

    1. GEOGRAPHICAL ANALYSIS
      • ASIA-PACIFIC
        • MARKET ESTIMATES & SIZES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • CHINA
          • JAPAN
          • INDIA
          • SOUTH KOREA
          • INDONESIA
          • SINGAPORE
          • TAIWAN
          • AUSTRALIA & NEW ZEALAND
          • REST OF ASIA-PACIFIC
    1. MARKET BY PRODUCT
      • EQUIPMENT
      • CONTRAST AGENT
    2. MARKET BY TYPE
      • NON-TARGETED
      • TARGETED
    3. MARKET BY END-USER
      • HOSPITALS
      • CLINICS
      • AMBULATORY DIAGNOSTIC CENTERS

    To request a free sample copy of this report, please complete the form below :

    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


      Choose License Type